PE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Proteus Syndrome (2)</title>
<style>
    body {
        font-family: Arial, sans-serif;
        margin: 40px;
        display: flex;
    }
    img {
        max-width: 30%;
        height: 100%;
        margin-right: 20px;
    }
    .content {
        max-width: 70%;
    }
</style>
</head>
<body>
<img src="../images/ProteusSyndrome2needtofindsource.jpg" alt="Historic medical illustration showing two portrait views of a person with features consistent with Proteus syndrome">
<div class="content">
<h1>Proteus Syndrome (2)</h1>

<h2>[a] Artist/ Group/Tribe</h2>
<p>
This image appears to be an anonymous medical illustration or photogravure derived from clinical photography, a common practice in European and North American teaching hospitals from the late nineteenth to early twentieth century. The “artist,” likely a physician-illustrator or medical photographer working with an engraver, sought to transform a living body into a didactic plate. Authorship is subordinated to clinical taxonomy: the subject is presented as a case rather than an individual, reflecting institutional priorities of documentation and comparison.
</p>

<h2>[b] Historical and Socio-Cultural context (time-frame)</h2>
<p>
The work belongs to the era when medical museums, atlases, and journals proliferated alongside new photographic technologies. Clinical image-making at hospitals such as the Salpêtrière and in Anglo-American institutions emphasized serial typologies of disease, aligning with wider nineteenth-century scientific ideals of objectivity. At the same time, such images coincided with popular spectacles of bodily difference, including fairs and traveling exhibitions. The medical plate therefore operated within intersecting economies of knowledge and display—disciplinary, pedagogical, and commercial—at a moment marked by classificatory zeal and emerging biomedical research cultures.
</p>

<h2>[c] Symbolism and/ or iconography</h2>
<p>
The paired bust-length views—profile and three-quarter—compose a comparative iconography. The circular vignettes isolate the head and torso, stripping context to emphasize asymmetry and textural surface. Light rakes across skin, highlighting lobulated masses and uneven contours. This visual rhetoric asserts diagnostic legibility: the body is framed as evidence. The circular format evokes the cameo or medallion, recoding a portrait genre into a specimen register. The repetition of the sitter under slightly different angles encourages the reader’s gaze to measure difference across planes, an iconography of comparison crucial to clinical reasoning.
</p>

<h2>[d] Stylistic Significance (elements of art/ principles of design)</h2>
<p>
Technically, stipple and cross-hatching create a granular tonal field, translating photographic values into printable line. The strong contour lines of the profile establish silhouette, while the denser hatching models protrusions and scars, producing a tactile illusion of relief. Balance is asymmetric by design; visual weight accumulates where growths are most pronounced. Rhythm is established through repeated circular frames, and emphasis is controlled via contrast between illuminated flesh and subdued background. The composition’s economy—cropped shoulders, neutral ground—aligns stylistic minimalism with clinical focus, privileging form and texture over narrative setting.
</p>

<h2>[e] Social / Cultural Inequities</h2>
<p>
Historically, bodies with visible difference were subject to extraction: images circulated in medical schools and print without robust consent frameworks, while subjects often lacked agency over representation. Economic precarity, disability stigma, and ableist norms shaped who appeared in atlases and how. The plate thus indexes inequities in authorship, privacy, and ownership of bodily images. Contemporary reflection urges recontextualization—centering dignity, avoiding sensationalism, and acknowledging the structural conditions that made such documentation possible and profitable for institutions but rarely for patients.
</p>

<h2>[f] Description of Disease & Etiology</h2>
<p>
Proteus syndrome is a rare, sporadic overgrowth disorder characterized by mosaic, asymmetric proliferation of bone, skin, adipose, and vasculature. The molecular etiology is a post-zygotic activating mutation in AKT1 (commonly c.49G&gt;A, p.E17K), producing somatic mosaicism and pathway hyperactivation within PI3K–AKT–mTOR signaling. Because only a subset of cells harbor the variant, clinical expression is patchy and segmental, often progressing through childhood. The condition is not inherited in a Mendelian fashion; rather, timing and lineage of the mutation determine distribution and severity of overgrowth.
</p>

<h2>[g] Pathology Signs/Signifiers of Illness</h2>
<p>
Cardinal findings include disproportionate, asymmetric overgrowth of limbs or craniofacial bones; cerebriform connective tissue nevi (particularly on soles); epidermal nevi; vascular malformations; and dysregulated adipose tissue. Craniofacial involvement may produce mandibular or maxillary hypertrophy, nasal or orbital asymmetry, and soft-tissue overgrowth altering facial contour—features the plate accentuates. Systemic complications include deep venous thrombosis and pulmonary embolism, scoliosis, and joint dysfunction. Differential diagnosis historically included neurofibromatosis type 1 and CLOVES; molecular testing of AKT1 now refines classification.
</p>

<h2>[h] Treatment</h2>
<p>
There is no curative therapy; management is multidisciplinary and individualized. Orthopedic and craniofacial surgeries may debulk overgrowths or correct alignment, balanced against risks of regrowth and scarring. Surveillance for thromboembolism is essential; prophylactic anticoagulation may be indicated perioperatively or in high-risk settings. Compression therapy, physiotherapy, and pain management support function. Targeted molecular approaches are under investigation: AKT inhibitors (e.g., miransertib/ARQ 092) and mTOR inhibition (e.g., sirolimus) have shown promise in case series, aiming to dampen pathway hyperactivation while monitoring adverse effects.
</p>

<h2>[i] Social Determinants of Illness</h2>
<p>
Outcomes are shaped by access to specialty care, genetic testing, and rehabilitative services, which often cluster in urban tertiary centers. Insurance coverage, travel capacity, and caregiver support determine continuity of care. Stigma and barriers to inclusive education and employment compound psychosocial stress, while built-environment inaccessibility can limit mobility after orthopedic interventions. Ethical representation in medical and cultural domains—patient consent, narrative control, and community involvement—also functions as a determinant, mediating exposure to discrimination and the availability of supportive networks.
</p>

<h2>[j] References and Citations</h2>
<ul>
<li>Lindhurst MJ et al. A mosaic activating mutation in AKT1 associated with Proteus syndrome. N Engl J Med. 2011. https://www.nejm.org/doi/full/10.1056/NEJMoa1104017</li>
<li>Keppler-Noreuil KM et al. Clinical delineation and natural history of Proteus syndrome. Orphanet J Rare Dis. 2014/2016. https://ojrd.biomedcentral.com/articles/10.1186/s13023-014-0219-8</li>
<li>Genetic and Rare Diseases Information Center (GARD): Proteus Syndrome. https://rarediseases.info.nih.gov/diseases/7430/proteus-syndrome</li>
<li>National Organization for Rare Disorders (NORD): Proteus Syndrome. https://rarediseases.org/rare-diseases/proteus-syndrome/</li>
<li>Daston L, Galison P. Objectivity. Zone Books, 2007. https://www.zonebooks.org/books/77-objectivity</li>
<li>Tagg J. The Burden of Representation: Essays on Photographies and Histories. 1988. https://www.routledge.com/The-Burden-of-Representation/Tagg/p/book/9781350061730</li>
<li>Gilman SL. Difference and Pathology: Stereotypes of Sexuality, Race, and Madness. 1985. https://press.ucalgary.ca/books/9780801832373/</li>
<li>Biesecker LG, Sapp JC. Proteus syndrome overview. GeneReviews. 2020. https://www.ncbi.nlm.nih.gov/books/NBK1147/</li>
</ul>

</div>
</body>
</ht